Your browser doesn't support javascript.
loading
Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer.
Flank, Jacqueline; Robinson, Paula D; Holdsworth, Mark; Phillips, Robert; Portwine, Carol; Gibson, Paul; Maan, Cathy; Stefin, Nancy; Sung, Lillian; Dupuis, L Lee.
Afiliação
  • Flank J; Department of Pharmacy, The Hospital for Sick Children, Toronto, Canada.
  • Robinson PD; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
  • Holdsworth M; Pediatric Oncology Group of Ontario, Toronto, Canada.
  • Phillips R; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico.
  • Portwine C; Regional Department of Haematology and Oncology, Leeds Children's Hospital, Leeds, United Kingdom.
  • Gibson P; Centre for Reviews and Dissemination, University of York, York, United Kingdom.
  • Maan C; Division of Hematology/Oncology, Department of Pediatrics, McMaster University, Hamilton, Canada.
  • Stefin N; Pediatric Hematology/Oncology, Children's Hospital, London Health Sciences Centre, London, Canada.
  • Sung L; Pediatric Hematology/Oncology, Children's Hospital, London Health Sciences Centre, London, Canada.
  • Dupuis LL; Division of Hematology/Oncology, Department of Pediatrics, McMaster University, Hamilton, Canada.
Pediatr Blood Cancer ; 63(7): 1144-51, 2016 Jul.
Article em En | MEDLINE | ID: mdl-26960036
ABSTRACT
This clinical practice guideline provides an approach to the treatment of breakthrough chemotherapy-induced nausea and vomiting (CINV) and the prevention of refractory CINV in children. It was developed by an international, interprofessional panel and is based on systematic literature reviews. Evidence-based interventions for the treatment of breakthrough and prophylaxis of refractory CINV are recommended. Gaps in the evidence used to support the recommendations made in this clinical practice guideline were identified. The contribution of these recommendations to breakthrough and refractory CINV control in children requires prospective evaluation.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Vômito / Náusea / Neoplasias Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Vômito / Náusea / Neoplasias Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Pediatr Blood Cancer Ano de publicação: 2016 Tipo de documento: Article